Infinium Pharmachem Ltd

NSE: INFINIUM · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹315.00
Market cap: ₹438.4 Cr
Revenue (annual): ₹189.6 Cr
Net profit (annual): ₹12.15 Cr
P/E (TTM): 36.1×Sector 47.4×
Promoter holding: 64.91%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Financial Results 2 Board Meeting Date 2 Annual General Meeting 2 SME to Main Board Migration 1 Management Change 1 Legal & Regulatory 1 Fund Raise 1 Credit Rating 1 Business Update 1 Board Meeting Outcome 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 Apr 2026 17:04 IST NSE

Adverse Business Impact

Infinium Pharmachem Adverse Business Impact

Infinium Pharmachem received a GPCB directive for the temporary closure of its Sojitra plant due to unauthorized waste disposal. The company must submit a ₹0.02 Crore bank guarantee. While production is halted, the company intends to maintain turnover for April 2026 by selling existing finished goods inventory.

Value: ₹0.02 Cr

Read the filing ↗